Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF in Septic Neonates
NCT01479114Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Apr 2009
- Primary completion
- May 2010
- Modality
- Cytokines & Interferons
01
Overview
Phase 4, randomised, double-blind trial of filgrastim in neonatal sepsis (3 arms), sponsored by Ain Shams University. Primary endpoint: All Cause Mortality at 1 month. Started Apr 2009; status: completed.
02
Drugs
filgrastim
03
Conditions
neonatal sepsis
Beyond the preview
Go deeper on NCT01479114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479114.